Lectures and Symposia

  • CADASIL
  • DRUGS FOR DEMENTIA I
  • DRUGS FOR DEMENTIA II
  • HOMOCYSTEINE, BLOOD PRESSURE AND DEMENTIA
  • VASCULAR COGNITIVE IMPAIRMENT: AN ENTITY EXPECTING NEW THERAPEUTIC COMMITMENTS 
    Sponsored By SSNN
  • BLOOD-BRAIN BARRIER AND ENDOTHELIAL DYSFUNCTION IN NEURODEGENERATION
  • ROUND TABLE: ' WHY HAVE WE FAILED IN FINDING THERAPY FOR VASCULAR DEMENTIA?'
    Sponsored By Solvay Pharmaceuticals
  • CEREBROVASCULAR REACTIVITY AND COGNITIVE IMPAIRMENT
  • INFLAMMATION AND IMMUNE RESPONSES IN VASCULAR DEMENTIA
  • BRING YOUR CASES
  • SLEEP AND DEMENTIA
  • VASCULAR COGNITIVE IMPAIRMENT: ANYTHING NEW?
    Sponsored By EBEWE
  • VASCULAR ENCEPHALOAPTHIES WITH DEMENTIA IN THE YOUNG
  • VASCULAR BRAIN DISORDERS: PATHOLOGY AND GENETICS
  • NEUROACANTHOCYTOSIS AND MELAS
  • THE COMPLEX EFFECT OF DIABETES ON COGNITION
  • VASCULAR BURDEN IN BRAIN AGING: COGNITIVE AND AFFECTIVE REPERCUSSIONS
  • POST-STROKE COGNITIVE IMPAIRMENT
  • VESSELS, BLOOD, COGNITION AND BEHAVIOUR
    Endorsed By WFN Research Group on dementia
  • MIGRAINE, STROKE AND DEMENTIA
  • BIOMARKERS FOR VASCULAR DEMENTIA
  • LIPIDS, STATINS AND DEMENTIA: CONTROVERSIES AND FUTURE DIRECTIONS
  • BIOLOGICAL MARKERS
  • NEUROPSYCHOLOGY
  • BREAKING NEWS SUBMISSION
  • FREE COMMUNICATIONS